Applied Therapeutics, Inc. — Director's Dealing 2022

Aug 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-08-02

Reporting Person: SKYLER JAY S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-02	Employee Stock Option (Right to Buy)	$1.22	D	16500	Disposed	2032-06-02	Common Stock (16500)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	16500	Acquired	2032-06-02	Common Stock (16500)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$19.70	D	16500	Disposed	2031-06-02	Common Stock (16500)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	16500	Acquired	2031-06-02	Common Stock (16500)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$44.02	D	10230	Disposed	2030-06-03	Common Stock (10230)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	10230	Acquired	2030-06-03	Common Stock (10230)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$10.00	D	20460	Disposed	2029-05-12	Common Stock (20460)	Direct
2022-08-02	Employee Stock Option (Right to Buy)	$1.05	D	20460	Acquired	2029-05-12	Common Stock (20460)	Direct

Footnotes

F1: The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.

F2: Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

F3: These Options are fully vested.